SpectraCure Stock Forward View - Simple Moving Average
| SPEC Stock | SEK 0.09 -0.0001 -0.11% |
For short-term price forecasting, SpectraCure's sentiment profile - captured through news flow and social engagement - can be as informative as any financial ratio. This module quantifies and translates that data into a price signal.
According to momentum metrics, SpectraCure reflects RSI of 0, indicating compressed downside momentum. At these depths, SpectraCure may be approaching exhaustion on the sell side, though timing a reversal requires additional confirmation.Momentum
Sell Peaked
Oversold | Overbought |
The hype perspective for SpectraCure AB maps headline activity to recent price response and peer coverage.
The Simple Moving Average forecasted value of SpectraCure AB on the next trading day is expected to be 0.09 with a mean absolute deviation of 0.0044 and the sum of the absolute errors of 0.27.SpectraCure after-hype prediction price | kr 0.09 |
Hype analysis provides context that aligns with forecasting models, technical indicators, and earnings views.
SpectraCure |
SpectraCure Additional Predictive Modules
Predictive models for SpectraCure combine technical indicators with statistical methods to estimate probable price trajectories. Model confidence should be calibrated against recent prediction accuracy for SpectraCure, not just historical fit.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Simple Moving Average Price Forecast For the 18th of March 2026
Given 90 days horizon, the Simple Moving Average forecasted value of SpectraCure AB on the next trading day is expected to be 0.09 with a mean absolute deviation of 0.0044 , mean absolute percentage error of 0.000048 , and the sum of the absolute errors of 0.27 .Please note that although there have been many attempts to predict SpectraCure Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that SpectraCure's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Stock Forecast Pattern
| Backtest SpectraCure | SpectraCure Price Prediction | Research Analysis |
Forecasted Value
For the next trading day, Macroaxis evaluates SpectraCure's predictive range by looking for statistically meaningful downside and upside boundaries. The projected forecast band currently runs from roughly 0.0009 on the downside to about 6.22 on the upside.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Moving Average forecasting method's relative quality and the estimations of the prediction error of SpectraCure stock data series using in forecasting. Note that when a statistical model is used to represent SpectraCure stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 106.3277 |
| Bias | Arithmetic mean of the errors | 0.0018 |
| MAD | Mean absolute deviation | 0.0044 |
| MAPE | Mean absolute percentage error | 0.0387 |
| SAE | Sum of the absolute errors | 0.2661 |
The degree to which SpectraCure's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
After-Hype Price Density Analysis
The after-hype price distribution for SpectraCure helps investors understand how much of SpectraCure's predicted return comes from the central scenario versus tail outcomes. Strategies that rely on tail events for SpectraCure are inherently more speculative.
Next price density |
| Expected price to next headline |
Estimiated After-Hype Price Volatility
Historical news patterns for SpectraCure reveal how the market has historically digested different types of information about SpectraCure's business and market environment. SpectraCure's after-hype downside and upside margins for the prediction period are 0.00 and 6.22, respectively. The model extrapolates these patterns to estimate likely price boundaries following the next significant.
Current Value
Macroaxis estimates the after-hype price of SpectraCure AB across a 3 months horizon to evaluate where the instrument could settle once headline distortion subsides. Used correctly, the estimate adds context around potential normalization rather than promising a specific realized outcome.
Price Outlook Analysis
Have you ever been surprised when a price of a Company such as SpectraCure is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading SpectraCure backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with SpectraCure, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.76 | 6.13 | 0.00 | 0.00 | 0 Events | 0 Events | Within a week |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.09 | 0.09 | 2.91 |
|
Hype Timeline
SpectraCure AB is at this time traded for 0.09on Stockholm Exchange of Sweden. The company stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. SpectraCure is anticipated to decline in value after the next headline, with the price expected to drop to 0.09. The average volatility of media hype impact on the company price is insignificant. The price decline on the next news is expected to be -2.91%, whereas the daily expected return is at this time at -0.76%. The volatility of related hype on SpectraCure is about 0.0%, with the expected price after the next announcement by competition of 0.09. About 21.0% of the company outstanding shares are owned by corporate insiders. The book value of SpectraCure was at this time reported as 1.61. The company recorded a loss per share of 0.26. SpectraCure AB had not issued any dividends in recent years. Assuming the 90-day trading horizon the next anticipated press release will be within a week. Cross-verify projections for SpectraCure using Historical Fundamental Analysis of SpectraCure. The analysis adds historical context for the projection set.Related Hype Analysis
Peer hype analysis helps investors build a more complete picture of SpectraCure's competitive environment by quantifying the market's sensitivity to news across all major players in SpectraCure's sector.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HEART | Real Heart | 0.00 | 0 per month | 0.00 | -0.03 | 4.00 | -3.15 | 9.67 | |
| LXB | Luxbright AB | 0.00 | 0 per month | 0.00 | -0.06 | 11.63 | -11.36 | 37.54 | |
| SPRINT | Sprint Bioscience AB | 0.00 | 0 per month | 2.81 | 0.12 | 6.25 | -5.05 | 36.91 | |
| ICO | Iconovo | 0.00 | 0 per month | 0.00 | -0.01 | 4.35 | -5.04 | 17.95 | |
| ATORX | Alligator Bioscience AB | 0.00 | 0 per month | 0.00 | -0.07 | 11.76 | -13.16 | 86.58 | |
| SPAGO | Spago Nanomedical AB | 0.00 | 0 per month | 4.45 | 0.05 | 9.09 | -8.33 | 44.42 | |
| IDLDX | Neovici Holding AB | 0.00 | 0 per month | 0.00 | -0.06 | 8.33 | -8.11 | 22.02 | |
| SDOS | ScandiDos AB | 0.00 | 0 per month | 0.00 | -0.02 | 3.77 | -4.17 | 13.50 | |
| EPIS-B | Episurf Medical AB | 0.00 | 0 per month | 6.59 | 0.15 | 23.11 | -9.88 | 56.29 | |
| SIMRIS-B | Simris Alg AB | 0.00 | 0 per month | 11.67 | 0.07 | 15.79 | -15.00 | 104.57 |
Other Forecasting Options for SpectraCure
The price trajectory of SpectraCure is the primary concern for any investor assessing it as an opportunity. SpectraCure Stock price charts are filled with noise that can easily mislead uninformed investment decisions.SpectraCure Related Equities
The following equities are related to SpectraCure within the Medical Devices space and can be used for peer comparison, relative valuation, or portfolio diversification. Comparing SpectraCure against peers on metrics such as P/E, margins, and return on equity helps contextualize its positioning and identify relative strengths or weaknesses.
| Risk & Return | Correlation |
SpectraCure Market Strength Events
Understanding the market strength of SpectraCure stock enables investors to assess the security's momentum and responsiveness to broader market forces. These indicators are essential tools for timing trades in SpectraCure AB with greater precision.
| Accumulation Distribution | 44824.51 | |||
| Daily Balance Of Power | -0.02 | |||
| Rate Of Daily Change | 1.0 | |||
| Day Median Price | 0.0924 | |||
| Day Typical Price | 0.0925 | |||
| Price Action Indicator | 3.0E-4 | |||
| Period Momentum Indicator | -0.0001 |
SpectraCure Risk Indicators
Reviewing SpectraCure's basic risk indicators is essential for investors who want to forecast its price and manage their investment risk effectively. This analysis helps identify the amount of risk involved in holding SpectraCure's and informs decisions about hedging and position.
| Mean Deviation | 3.49 | |||
| Standard Deviation | 5.97 | |||
| Variance | 35.67 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for SpectraCure
Story coverage around SpectraCure AB often expands when market conditions, narrative momentum, or risk-adjusted performance make the security more visible to investors. The stronger process compares story flow with performance, theme classification, and the level of short-term market interest.
Other Macroaxis Stories
Macroaxis publishes story content for a diverse readership that includes finance students, independent investors, money managers, and market-focused operating teams. What connects that audience is a focus on building stronger portfolios through better research, risk awareness, and comparative analysis.
Story Categories
Currently Trending Categories
SpectraCure Short Properties
Short-interest signals around SpectraCure AB can help investors judge whether skeptical positioning is starting to pressure price predictability and market tone. Used correctly, these measures can help investors decide when hedging or timing discipline may matter more than conviction alone.
| Common Stock Shares Outstanding | 107.5 M | |
| Cash And Short Term Investments | 129.7 M |
Additional Tools for SpectraCure Stock Analysis
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |